A phase I/II study to evaluate the safety, pharmacokinetics, and efficacy of PRJ1-3024 in patients with advanced solid tumors

被引：0
|
作者：
Zhang, Panpan
Qin, Yanru
Gong, Jifang
Wang, Yongsheng
Yang, Kunyu
Li, Yongsheng
Dai, Guanghai
Zhu, Ji
Sha, Sha
Tong, Ming
Liao, Xuebin
Shen, Lin
机构：
[1] Peking Univ Canc Hosp & Inst, Beijing, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosital 1, Zhengzhou, Peoples R China
[3] Beijing Canc Hosp, Dept Gastrooncol, Beijing, Peoples R China
[4] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
[5] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China
[6] Chongqing Canc Hosp, Chongqing, Peoples R China
[7] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[8] Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China
[9] Zhuhai Yufan Biotechnol Co Ltd, Zhuhai, Guangdong, Peoples R China
[10] Tsinghua Univ, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2590
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors
    Yan, Zhao
    Zhu, Zhongling
    Li, Kai
    Chen, Peng
    Wang, Liuchun
    Huang, Chun
    Xue, Jinhuai
    Liu, Meijun
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (04) : 955 - 961
  • [32] A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors
    Zhao Yan
    Zhongling Zhu
    Kai Li
    Peng Chen
    Liuchun Wang
    Chun Huang
    Jinhuai Xue
    Meijun Liu
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 955 - 961
  • [33] Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid Tumors
    Batist, Gerald
    Gelmon, Karen A.
    Chi, Kim N.
    Miller, Wilson H., Jr.
    Chia, Stephen K. L.
    Mayer, Lawrence D.
    Swenson, Christine E.
    Janoff, Andrew S.
    Louie, Arthur C.
    CLINICAL CANCER RESEARCH, 2009, 15 (02) : 692 - 700
  • [34] EARLY RESULTS FROM A PHASE 1 STUDY TO EVALUATE SAFETY, PHARMACOKINETICS, AND EFFICACY OF AMG 404, A PROGRAMMED DEATH-1 (PD-1) ANTIBODY, IN PATIENTS WITH ADVANCED SOLID TUMORS
    Price, Timothy
    Chawla, Sant
    Falchook, Gerald
    Prenen, Hans
    Lugowska, Iwona
    Subbiah, Vivek
    Monzon, Jose
    Ozawa, Yuichi
    Arkenau, Tobias
    Lima, Caio Rocha
    Kuboki, Yasutoshi
    Nishina, Tomohiro
    Hui, Mun
    Rasmussen, Erik
    Wong, Hansen
    Najmi, Saltanat
    Sadraei, Nooshin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A245 - A245
  • [35] A Phase I Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Patients with Select Advanced Solid Tumors
    Ma, Yuxiang
    Fang, Wenfeng
    Zhao, Hongyun
    Bathena, Sai Praneeth
    Tendolkar, Amol
    Sheng, Jennifer
    Zhang, Li
    ONCOLOGIST, 2021, 26 (04): : E549 - E566
  • [36] Phase I study of the safety and pharmacokinetics of epitinib, an oral EGFR tyrosine kinase inhibitor, in patients with advanced solid tumors
    Zhou, Qing
    Wu, Yi Long
    Yu, Xiyong
    Yang, Jinji
    Wen, Limin
    Sai, Yang
    Mu, Hua
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors
    Leong, Stephen
    Moss, Rebecca A.
    Bowles, Daniel W.
    Ware, Joseph A.
    Zhou, Jing
    Spoerke, Jill M.
    Lackner, Mark R.
    Shankar, Geetha
    Schutzman, Jennifer L.
    van der Noll, Ruud
    Voest, Emile E.
    Schellens, Jan H. M.
    ONCOLOGIST, 2017, 22 (12): : 1491 - 1499
  • [38] Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors
    Maguire, William F.
    Schmitz, John C.
    Scemama, Jonas
    Czambel, Ken
    Lin, Yan
    Green, Anthony G.
    Wu, Shaoyu
    Lin, Huang
    Puhalla, Shannon
    Rhee, John
    Stoller, Ronald
    Tawbi, Hussein
    Lee, James J.
    Wright, John J.
    Beumer, Jan H.
    Chu, Edward
    Appleman, Leonard J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (04) : 643 - 654
  • [39] A Phase I Study of the Pharmacokinetics and Safety of Ipatasertib, an Akt Inhibitor in Chinese Patients With Locally Advanced or Metastatic Solid Tumors
    Zhang, Jian
    Liu, Rujiao
    Sutaria, Dhruvit
    Sane, Rucha
    Fan, Minhao
    Wang, Rui
    Song, Grace
    Chen, Kui
    Arzumanova, Ksenia
    Hu, Xichun
    CLINICAL THERAPEUTICS, 2025, 47 (02) : 128 - 134
  • [40] Phase I study of enzastaurin and bevacizumab in patients with advanced cancer: safety, efficacy and pharmacokinetics
    Nwabundo Nwankwo
    Zhe Zhang
    Ting Wang
    Connie Collins
    Lee Resta
    Sabine Ermisch
    Jeannette Day
    Rodney Decker
    Lori Kornberg
    Steven Nicol
    Donald Thornton
    Deborah K. Armstrong
    Michael A. Carducci
    Investigational New Drugs, 2013, 31 : 653 - 660
12345